CDC-RFA-PW-25-2500: Preventive Health and Health Services Block Grant – 2025 CDC-RFA-PW-25-2500
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control-PHIC notices from 2025.
Centers for Disease Control-PHIC offered grants to state and local governments. It expected to make about 61 awards worth $162 million in total. Applications closed on July 31, 2025.
From the official notice on Grants.gov, last changed June 27, 2025. Checked November 7, 2026.
- Total funding$162 million
- Expected awards61
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | June 27, 2025 |
|---|---|
| Deadline | July 31, 2025 |
| Archived by Grants.gov | August 30, 2025 |
Who can apply
This opportunity was open to state and local governments.
- State governments
This program provides all 50 US states (State Health Departments), the District of Columbia, 2 American Indian Tribes (Santee Sioux; Kickapoo Tribe, KS), 5 U.S. Territories (Commonwealth of Northern Mariana Islands, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Republic of Palau) and 3 Freely Associated States (Puerto Rico, US Virgin Islands, American Samoa) as identified in the authorizing statute with funding to address their own unique public health needs and challenges with innovative and locally defined methods.
Is this a realistic fit?
- Most of the program's money (96% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The Preventive Health and Health Services (PHHS) Block Grant Program allows recipients to address their own unique public health needs and challenges with evidence based, innovative and community-driven methods. Recipients set their own goals and program objectives to address local priorities.
Who has won Preventive Health and Health Services Block Grant grants before
From fiscal 2021 to 2025, Preventive Health and Health Services Block Grant (93.991) awarded $721 million across 303 grant awards, an average of $2.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| NYS Department of Health | New York | 5 | $56.1 million |
| California Department of Public Health | California | 5 | $54.1 million |
| Pennsylvania Department of Health | Pennsylvania | 5 | $39.0 million |
| Ohio Department of Health | Ohio | 5 | $36.0 million |
| Department of State Health Services | Texas | 5 | $33.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-PW-25-2500 still open?
No. It closed on July 31, 2025.
Who can apply for Preventive Health and Health Services Block Grant – 2025 CDC-RFA-PW-25-2500?
Centers for Disease Control-PHIC accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.
What is the deadline for Preventive Health and Health Services Block Grant – 2025 CDC-RFA-PW-25-2500?
Closed July 31, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $162 million in total across about 61 awards.
Who has won Preventive Health and Health Services Block Grant grants before?
The largest recipients over five fiscal years were NYS Department of Health, California Department of Public Health, Pennsylvania Department of Health. The program made 303 awards worth $721 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)